227 related articles for article (PubMed ID: 19602458)
1. Molecular and immunohistochemical analyses of BCL2, KI-67, and cyclin D1 expression in synovial sarcoma.
Krsková L; Kalinová M; Brízová H; Mrhalová M; Sumerauer D; Kodet R
Cancer Genet Cytogenet; 2009 Aug; 193(1):1-8. PubMed ID: 19602458
[TBL] [Abstract][Full Text] [Related]
2. G3139 antisense oligonucleotide directed against antiapoptotic Bcl-2 enhances doxorubicin cytotoxicity in the FU-SY-1 synovial sarcoma cell line.
Joyner DE; Albritton KH; Bastar JD; Randall RL
J Orthop Res; 2006 Mar; 24(3):474-80. PubMed ID: 16450387
[TBL] [Abstract][Full Text] [Related]
3. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
[TBL] [Abstract][Full Text] [Related]
4. Nuclear beta-catenin correlates with cyclin D1 expression in spindle and pleomorphic sarcomas but not in synovial sarcoma.
Saito T; Oda Y; Yamamoto H; Kawaguchi K; Tanaka K; Matsuda S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2006 Jun; 37(6):689-97. PubMed ID: 16733209
[TBL] [Abstract][Full Text] [Related]
5. Molecular and immunohistochemical analysis of ERBB2 expression in correlation with proliferation rate in synovial sarcoma.
Krsková L; Kalinová M; Brizová H; Mrhalová M; Sumerauer D; Kodet R
Diagn Mol Pathol; 2007 Dec; 16(4):211-7. PubMed ID: 18043284
[TBL] [Abstract][Full Text] [Related]
6. Oncoproteins and proliferation markers in synovial sarcomas: a clinicopathologic study of 19 cases.
Barbashina V; Benevenia J; Aviv H; Tsai J; Patterson F; Aisner S; Cohen S; Fernandes H; Skurnick J; Hameed M
J Cancer Res Clin Oncol; 2002 Nov; 128(11):610-6. PubMed ID: 12458341
[TBL] [Abstract][Full Text] [Related]
7. c-KIT and c-KIT ligand (SCF) in synovial sarcoma (SS): an mRNA expression analysis in 23 cases.
Tamborini E; Papini D; Mezzelani A; Riva C; Azzarelli A; Sozzi G; Pierotti MA; Pilotti S
Br J Cancer; 2001 Aug; 85(3):405-11. PubMed ID: 11487273
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms.
Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D
In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405
[TBL] [Abstract][Full Text] [Related]
9. TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases.
Knösel T; Heretsch S; Altendorf-Hofmann A; Richter P; Katenkamp K; Katenkamp D; Berndt A; Petersen I
Eur J Cancer; 2010 Apr; 46(6):1170-6. PubMed ID: 20189377
[TBL] [Abstract][Full Text] [Related]
10. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.
Jagdis A; Rubin BP; Tubbs RR; Pacheco M; Nielsen TO
Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272
[TBL] [Abstract][Full Text] [Related]
12. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin G is present in a wide variety of soft tissue tumors and correlates well with proliferation markers and tumor grades.
Chen Z; Huang X; Ye J; Pan P; Cao Q; Yang B; Li Z; Su M; Huang C; Gu J
Cancer; 2010 Apr; 116(8):1953-63. PubMed ID: 20186824
[TBL] [Abstract][Full Text] [Related]
14. p16INK4A (CDKN2A) gene deletion is a frequent genetic event in synovial sarcomas.
Subramaniam MM; Noguera R; Piqueras M; Navarro S; López-Guerrero JA; Llombart-Bosch A
Am J Clin Pathol; 2006 Dec; 126(6):866-74. PubMed ID: 17074682
[TBL] [Abstract][Full Text] [Related]
15. Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases.
Coindre JM; Pelmus M; Hostein I; Lussan C; Bui BN; Guillou L
Cancer; 2003 Dec; 98(12):2700-7. PubMed ID: 14669292
[TBL] [Abstract][Full Text] [Related]
16. Correlation of cyclin D1 transcript levels, transcript type and protein expression with proliferation and histology among mantle cell lymphoma.
Shakir R; Ngo N; Naresh KN
J Clin Pathol; 2008 Aug; 61(8):920-7. PubMed ID: 18552173
[TBL] [Abstract][Full Text] [Related]
17. Extent, relationship and prognostic significance of apoptosis and cell proliferation in synovial sarcoma.
Sun B; Sun Y; Wang J; Zhao X; Wang X; Hao X
Eur J Cancer Prev; 2006 Jun; 15(3):258-65. PubMed ID: 16679870
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
[TBL] [Abstract][Full Text] [Related]
19. Cytologic features of synovial sarcoma with emphasis on the monophasic fibrous variant: a morphologic and immunocytochemical analysis of bcl-2 protein expression.
Viguer JM; Jiménez-Heffernan JA; Vicandi B; López-Ferrer P; Gamallo C
Cancer; 1998 Feb; 84(1):50-6. PubMed ID: 9500652
[TBL] [Abstract][Full Text] [Related]
20. Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2.
Chuang SS; Huang WT; Hsieh PP; Tseng HH; Campo E; Colomer D; Ye H; Lu CL; Chang HM; Cho CY; Huang SH; Lu YC; Wu JD
Pathol Int; 2006 Aug; 56(8):440-8. PubMed ID: 16872438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]